Mark Holst

Mark Holst is a seasoned professional in clinical trial management with extensive experience in leading and overseeing global clinical studies. Mark currently serves as a Senior Manager, Clinical Trial Lead at Biogen, where responsibilities include developing operational strategies and chairing study management teams. Prior roles include overseeing global interventional trials at Bristol Myers Squibb and serving as Clinical Country Lead at Biogen, demonstrating a strong capability in coordinating cross-functional teams and aligning clinical development strategies with local operational needs. Mark's career also encompasses significant roles at organizations such as Syneos Health, AbbVie, Hospira, Baxter International, SCIREX Corporation, and Abbott, where Mark successfully managed clinical project timelines, budgets, and compliance for various phases of clinical research, contributing to multiple FDA approvals and advancing drug development initiatives. Mark holds a Bachelor’s Degree in General Sciences from the University of Iowa.